作者:
Spielmann,M. [1]
;
Luporsi,E. [2]
;
Ray-Coquard,I. [3]
;
DeBotton,S. [4]
;
Azria,D. [5]
;
Lasocki,S. [6]
;
Lafuma,A. [7]
;
Mahi,L. [8]
;
Deray,G. [9]
;
Bugat,R. [10]
作者单位:
Hematology Department, Institut Gustave Roussy, Villejuif, France
[1]
Medical Oncology Department, Institut Gustave Roussy, Villejuif, France
[2]
Oncology and Radiotherapy Department, CRLC Val d'Aurelle, Montpellier, France
[3]
Medical Oncology Department, Centre Léon Berard, EAM 4129 SIS, Lyon, France
[4]
Critical Care Medicine Department, H?pital Bichat, Paris, France
[5]
CEMKA EVAL, Bourg-la-Reine, France
[6]
VIFOR Pharma, 7-13 boulevard Paul-Emile Victor, 92521 Neuilly-sur-Seine Cedex, France
[7]
Nephrology Department, H?pital Pitié-Salpêtrire, Paris, France
[8]
Medical Oncology Department, Centre Alexis Vautrin, Vand?uvre-ls-Nancy, France
[9]
Medical Oncology Department, Centre Claudius Regaud, Toulouse, France
[10]
发布时间
2013-11-20